Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sabbatini

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Oncology (Williston Park, N.Y.)|February 24, 2001
Contribution of anemia to fatigue in the cancer patientP Sabbatini
The Oncologist|July 15, 2000
The relationship between anemia and quality of life in cancer patientsP Sabbatini
Oncology (Williston Park, N.Y.)|June 30, 1998
Salvage therapy for ovarian cancerP Sabbatini, D Spriggs
The Journal of Biological Chemistry|August 14, 1999
Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosisP Sabbatini, F McCormick
Current Treatment Options in Oncology|June 12, 2002
Advanced ovarian cancerD S Chi, P Sabbatini
FEBS Letters|November 16, 1987
Carrier-free 8-azidoadenosine 5'-[gamma-32P]triphosphateG P Sabbatini, C von Holt
Molecular and Cellular Biology|October 1, 1996
Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19KJ Han, P Sabbatini, E White
Current Opinion in Oncology|November 4, 1998
Chemotherapy in gynecologic cancerP Sabbatini, C Aghajanian, D Spriggs
Seminars in Oncology|March 11, 1999
Implementation of disease management guidelines in patients with advanced ovarian cancerM L Hensley, P Sabbatini, D Spriggs
Current Opinion in Obstetrics & Gynecology|February 27, 1999
Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinomaS Makhija, P Sabbatini, R R Barakat
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|February 24, 2001
Contribution of anemia to fatigue in the cancer patientP Sabbatini
The Oncologist|July 15, 2000
The relationship between anemia and quality of life in cancer patientsP Sabbatini
Oncology (Williston Park, N.Y.)|June 30, 1998
Salvage therapy for ovarian cancerP Sabbatini, D Spriggs
The Journal of Biological Chemistry|August 14, 1999
Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosisP Sabbatini, F McCormick
Current Treatment Options in Oncology|June 12, 2002
Advanced ovarian cancerD S Chi, P Sabbatini
FEBS Letters|November 16, 1987
Carrier-free 8-azidoadenosine 5'-[gamma-32P]triphosphateG P Sabbatini, C von Holt
Molecular and Cellular Biology|October 1, 1996
Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19KJ Han, P Sabbatini, E White
Current Opinion in Oncology|November 4, 1998
Chemotherapy in gynecologic cancerP Sabbatini, C Aghajanian, D Spriggs
Seminars in Oncology|March 11, 1999
Implementation of disease management guidelines in patients with advanced ovarian cancerM L Hensley, P Sabbatini, D Spriggs
Current Opinion in Obstetrics & Gynecology|February 27, 1999
Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinomaS Makhija, P Sabbatini, R R Barakat
Pageof 5